ArticleRadiology case reports2026
Intracranial solitary fibrous tumor with multiloculated cystic change: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial solitary fibrous tumor (SFT) is a mesenchymal neoplasm that typically appears as a solid mass, whereas cases with predominantly cystic change are extremely uncommon. We report a case of intracranial SFT presenting as a cystic lesion. A 67-year-old woman presented with progressive memory impairment and gait instability over a 6-month period. CT and MRI revealed a mass located along the falx cerebri, composed predominantly of cystic components. The patient underwent surgical tumor resection, and histopathological examination confirmed the diagnosis of SFT, CNS WHO grade 2. Postoperative radiotherapy was administered, and no evidence of recurrence was observed during a 2-year follow-up period. Because SFT is an aggressive tumor with a high risk of recurrence and distant metastasis, accurate diagnosis is essential for appropriate treatment planning and postoperative surveillance. Therefore, SFT should be included in the differential diagnosis of intracranial tumors with cystic morphology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.